Breaking News Instant updates and real-time market news.

AAPL

Apple

$157.94

0.09 (0.06%)

07:46
01/03/19
01/03
07:46
01/03/19
07:46

Apple price target lowered to $211 from $236 at Morgan Stanley

Morgan Stanley analyst Katy Huberty noted that Apple's pre-announcement about first quarter weakness due to Greater China iPhone sales was the company's first negative warning in over 15 years. In early December, she had lowered her FY19 iPhone shipments by 13M, or 6%, to 200M, but following the company's warning she is now taking her forecast of FY19 iPhone units down by another 20M, to 180.25M, Huberty noted. She lowered her price target on Apple shares to $211 from $236 but keeps an Overweight rating on the stock, calling the company's platform story "alive and well."

AAPL Apple
$157.94

0.09 (0.06%)

01/03/19
JEFF
01/03/19
DOWNGRADE
JEFF
Hold
Apple downgraded to Hold from Buy at Jefferies
01/03/19
ADAM
01/03/19
NO CHANGE
Target $75
ADAM
Buy
FTC case could lead to settlement between Qualcomm and Apple, says Canaccord
Canaccord analyst T. Michael Walkley said the upcoming FTC case is an important step in the process towards Qualcomm (QCOM) and Apple (AAPL) reaching a licensing settlement. The analyst noted that in a partial summary judgment, it required Qualcomm to license cellular standard-essential patents to the Alliance for Telecommunications Industry Standards, presenting potential risks to its licensing practices. Walkley maintains his Buy rating and $75 price target on Qualcomm shares.
01/03/19
UBSW
01/03/19
NO CHANGE
Target $180
UBSW
Buy
Apple price target lowered to $180 from $210 at UBS
UBS analyst Timothy Arcuri lowered his price target on Apple to $180 from $210 following its announcement that Q1 results would fall short of estimates. The company cited weaker demand in China but gross margins were also at the low end of guidance. The analyst said the magnitude of the year-over-year decline was last seen during the iPhone 6s cycle due to very tough iPhone 6 comps. Arcuri maintains his Buy rating on Apple shares.
01/03/19
UBSW
01/03/19
NO CHANGE
Target $57
UBSW
Neutral
Apple shortfall sheds light on Best Buy challenges, says UBS
UBS analyst Michael Lassoer said Apple's (AAPL) pre-announcement sheds some light on the challenges ahead for Best Buy (BBY). He noted the company cited China for its shortfall, but the analyst said Best Buy is one of its key vendor partners and he believes Apple could account for roughly 15-20% of Best Buy's sales. He said its products drive traffic and motivate consumers to go to Best Buy stores. He said Apple's expanded distribution poses a risk to Best Buy as it will be harder for it to maintain its share gains. Lassoer lowered his price target to $57 from $70 and maintained his Neutral rating on Best Buy.

TODAY'S FREE FLY STORIES

TNK

Teekay Tankers

$2.39

0.155 (6.94%)

06:06
11/18/19
11/18
06:06
11/18/19
06:06
Upgrade
Teekay Tankers rating change  »

Teekay Tankers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELS

Equity Lifestyle

$69.44

0.795 (1.16%)

06:05
11/18/19
11/18
06:05
11/18/19
06:05
Upgrade
Equity Lifestyle rating change  »

Equity Lifestyle upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

MU

Micron

$47.70

0.88 (1.88%)

, WDC

Western Digital

$50.34

-0.03 (-0.06%)

06:05
11/18/19
11/18
06:05
11/18/19
06:05
Periodicals
U.S. to extend license allowing companies to do business with Huawei, NYT says »

The Trump administration…

MU

Micron

$47.70

0.88 (1.88%)

WDC

Western Digital

$50.34

-0.03 (-0.06%)

OCLR

Bought by LITE

$0.00

(0.00%)

ACIA

Acacia Communications

$67.08

0.58 (0.87%)

NPTN

NeoPhotonics

$8.57

0.08 (0.94%)

LITE

Lumentum

$68.91

0.91 (1.34%)

IIVI

II-VI

$29.45

0.19 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

  • 09

    Dec

AVEO

Aveo Pharmaceuticals

$0.64

-0.0088 (-1.37%)

06:05
11/18/19
11/18
06:05
11/18/19
06:05
Hot Stocks
Aveo Pharmaceuticals presents new data from Phase 3 TIVO-3 trial of tivozanib »

AVEO Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$23.99

2.5 (11.63%)

06:05
11/18/19
11/18
06:05
11/18/19
06:05
Downgrade
Amarin rating change  »

Amarin downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

WRK

WestRock

$39.50

-0.52 (-1.30%)

06:04
11/18/19
11/18
06:04
11/18/19
06:04
Upgrade
WestRock rating change  »

WestRock upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCOM

j2 Global

$95.90

1.17 (1.24%)

06:04
11/18/19
11/18
06:04
11/18/19
06:04
Initiation
j2 Global initiated  »

j2 Global initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

  • 09

    Dec

ELS

Equity Lifestyle

$69.44

0.795 (1.16%)

06:03
11/18/19
11/18
06:03
11/18/19
06:03
Upgrade
Equity Lifestyle rating change  »

Equity Lifestyle upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

KRTX

Karuna Therapeutics

$17.26

-0.26 (-1.48%)

06:02
11/18/19
11/18
06:02
11/18/19
06:02
Hot Stocks
Karuna Therapeutics: KarXT met primary endpoint in Phase 2 trial »

Karuna Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGFEY

Eurobank

$0.00

(0.00%)

06:01
11/18/19
11/18
06:01
11/18/19
06:01
Upgrade
Eurobank rating change  »

Eurobank upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$119.15

2.15 (1.84%)

06:01
11/18/19
11/18
06:01
11/18/19
06:01
Upgrade
Splunk rating change  »

Splunk upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CANG

Cango

$6.79

-0.05 (-0.73%)

06:00
11/18/19
11/18
06:00
11/18/19
06:00
Downgrade
Cango rating change  »

Cango downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$165.93

1.17 (0.71%)

06:00
11/18/19
11/18
06:00
11/18/19
06:00
Downgrade
Workday rating change  »

Workday downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

SFTBF

SoftBank

$0.00

(0.00%)

, SFTBY

SoftBank

$0.00

(0.00%)

06:00
11/18/19
11/18
06:00
11/18/19
06:00
Hot Stocks
SoftBank-backed Yahoo Japan set to merge with Naver's Line »

SoftBank Group announced…

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTC

Elastic

$74.06

1.94 (2.69%)

05:59
11/18/19
11/18
05:59
11/18/19
05:59
Upgrade
Elastic rating change  »

Elastic upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

OKTA

Okta

$117.45

1.45 (1.25%)

05:59
11/18/19
11/18
05:59
11/18/19
05:59
Downgrade
Okta rating change  »

Okta downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 16

    Dec

NBGIF

National Bank of Greece

$0.00

(0.00%)

05:57
11/18/19
11/18
05:57
11/18/19
05:57
Upgrade
National Bank of Greece rating change  »

National Bank of Greece…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPIRD

Piraeus Bank

$0.00

(0.00%)

05:57
11/18/19
11/18
05:57
11/18/19
05:57
Upgrade
Piraeus Bank rating change  »

Piraeus Bank upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MUFG

Mitsubishi UFJ

$5.39

0.095 (1.79%)

05:56
11/18/19
11/18
05:56
11/18/19
05:56
Downgrade
Mitsubishi UFJ rating change  »

Mitsubishi UFJ downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISSDY

ISS

$0.00

(0.00%)

05:55
11/18/19
11/18
05:55
11/18/19
05:55
Downgrade
ISS rating change  »

ISS downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMKBY

AP Moller Maersk

$0.00

(0.00%)

05:53
11/18/19
11/18
05:53
11/18/19
05:53
Downgrade
AP Moller Maersk rating change  »

AP Moller Maersk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$78.05

1.18 (1.54%)

05:53
11/18/19
11/18
05:53
11/18/19
05:53
Conference/Events
T-Mobile to host business news update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

BUD

AB InBev

$79.69

0.56 (0.71%)

05:52
11/18/19
11/18
05:52
11/18/19
05:52
Upgrade
AB InBev rating change  »

AB InBev upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

ADDYY

Adidas

$0.00

(0.00%)

05:52
11/18/19
11/18
05:52
11/18/19
05:52
Upgrade
Adidas rating change  »

Adidas upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

QD

Qudian

$7.49

-0.115 (-1.51%)

05:51
11/18/19
11/18
05:51
11/18/19
05:51
Earnings
Qudian reports Q3 EPS 47c, consensus 47c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.